Literature DB >> 24172851

Inhalation solutions--which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers--update 2013.

Wolfgang Kamin1, Frank Erdnüss2, Irene Krämer2.   

Abstract

Many patients suffering from chronic respiratory diseases rely on inhalation therapy with nebulizers. About 25% of patients who need to inhale several different drugs per day save time by mixing them for simultaneous inhalation. This review presents a comprehensive overview of the available data concerning physico-chemical compatibility of commonly mixed nebulizer solutions and suspensions. Information is based on our in vitro studies and a thorough literature search. Results indicate that many nebulizer solutions/suspensions are mixable without provoking incompatibilities. However, certain excipients contained in some of the tested drug products could be identified as a reason for incompatibilities, e.g. impaired activity of dornase alfa. Studies assessing the aerosol characteristics of compatible mixtures nebulized with commonly used nebulizers are limited and should be encouraged. The clinical efficacy of simultaneous inhalation of duplicate, tripartite or quadripartite mixtures must be evaluated in clinical studies before final recommendations for the inhalation regimens can be made.
© 2013. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. All rights reserved.

Entities:  

Keywords:  Aerosol; Compatibility; Mixture; Nebulizer solution/suspension; Review

Mesh:

Substances:

Year:  2013        PMID: 24172851     DOI: 10.1016/j.jcf.2013.09.006

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  3 in total

1.  Production and Clinical Application of the First Iranian Ultrasonic Desktop Nebulizer.

Authors:  Mansour Siavash; Ali Rahrovi; Shokooh Olamazadeh; Morteza Esmaili
Journal:  Adv Biomed Res       Date:  2018-07-20

2.  Characterization and comparison of Re-Du-Ning aerosol particles generated by different jet nebulizers.

Authors:  Yi Zhang; Brian Chi-Yan Cheng; Cui Li; Yonghua Tao; Chanjuan Yu; Xinyue Liu; Xiaoyan Gao; Gan Luo
Journal:  RSC Adv       Date:  2019-09-25       Impact factor: 4.036

3.  Aerosol delivery practice in Italian Cystic Fibrosis centres: a national survey.

Authors:  Simone Gambazza; Federica Carta; Anna Brivio; Carla Colombo
Journal:  Arch Physiother       Date:  2016-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.